nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SLC9A1—exocrine gland—esophageal cancer	0.0286	0.0746	CbGeAlD
Amiloride—SLC22A4—larynx—esophageal cancer	0.0229	0.0598	CbGeAlD
Amiloride—PLAU—neck—esophageal cancer	0.0173	0.0452	CbGeAlD
Amiloride—SCNN1D—epithelium—esophageal cancer	0.0132	0.0345	CbGeAlD
Amiloride—SCNN1G—bronchus—esophageal cancer	0.013	0.034	CbGeAlD
Amiloride—SLC9A1—epithelium—esophageal cancer	0.0124	0.0325	CbGeAlD
Amiloride—SLC9A1—bronchus—esophageal cancer	0.0122	0.032	CbGeAlD
Amiloride—SLC9A1—smooth muscle tissue—esophageal cancer	0.012	0.0313	CbGeAlD
Amiloride—PLAU—epithelium—esophageal cancer	0.0118	0.0308	CbGeAlD
Amiloride—PLAU—bronchus—esophageal cancer	0.0116	0.0303	CbGeAlD
Amiloride—PLAU—smooth muscle tissue—esophageal cancer	0.0114	0.0296	CbGeAlD
Amiloride—SCNN1B—epithelium—esophageal cancer	0.0112	0.0292	CbGeAlD
Amiloride—SCNN1B—bronchus—esophageal cancer	0.011	0.0287	CbGeAlD
Amiloride—PLAU—trachea—esophageal cancer	0.0104	0.0272	CbGeAlD
Amiloride—SCNN1A—epithelium—esophageal cancer	0.0103	0.0269	CbGeAlD
Amiloride—SCNN1A—bronchus—esophageal cancer	0.0102	0.0265	CbGeAlD
Amiloride—SCNN1B—trachea—esophageal cancer	0.00988	0.0258	CbGeAlD
Amiloride—AOC1—digestive system—esophageal cancer	0.00987	0.0258	CbGeAlD
Amiloride—SLC9A1—digestive system—esophageal cancer	0.00946	0.0247	CbGeAlD
Amiloride—SCNN1A—trachea—esophageal cancer	0.00913	0.0238	CbGeAlD
Amiloride—PLAU—digestive system—esophageal cancer	0.00897	0.0234	CbGeAlD
Amiloride—SCNN1D—lung—esophageal cancer	0.0084	0.0219	CbGeAlD
Amiloride—SCNN1G—lung—esophageal cancer	0.0084	0.0219	CbGeAlD
Amiloride—SLC9A1—lung—esophageal cancer	0.0079	0.0206	CbGeAlD
Amiloride—SCNN1A—digestive system—esophageal cancer	0.00785	0.0205	CbGeAlD
Amiloride—Diuresis—Cisplatin—esophageal cancer	0.00758	0.0602	CcSEcCtD
Amiloride—PLAU—lung—esophageal cancer	0.00749	0.0195	CbGeAlD
Amiloride—SCNN1B—lung—esophageal cancer	0.0071	0.0185	CbGeAlD
Amiloride—SCNN1A—lung—esophageal cancer	0.00656	0.0171	CbGeAlD
Amiloride—SLC22A4—neck—esophageal cancer	0.00608	0.0159	CbGeAlD
Amiloride—SCNN1D—lymph node—esophageal cancer	0.00575	0.015	CbGeAlD
Amiloride—ASIC1—lymph node—esophageal cancer	0.00564	0.0147	CbGeAlD
Amiloride—AOC1—lymph node—esophageal cancer	0.00564	0.0147	CbGeAlD
Amiloride—SLC9A1—lymph node—esophageal cancer	0.0054	0.0141	CbGeAlD
Amiloride—PLAU—lymph node—esophageal cancer	0.00512	0.0134	CbGeAlD
Amiloride—SCNN1B—lymph node—esophageal cancer	0.00486	0.0127	CbGeAlD
Amiloride—SCNN1A—lymph node—esophageal cancer	0.00449	0.0117	CbGeAlD
Amiloride—SLC22A2—digestive system—esophageal cancer	0.00424	0.0111	CbGeAlD
Amiloride—SLC22A4—bronchus—esophageal cancer	0.00407	0.0106	CbGeAlD
Amiloride—SLC22A4—trachea—esophageal cancer	0.00366	0.00955	CbGeAlD
Amiloride—SLC22A4—digestive system—esophageal cancer	0.00315	0.00821	CbGeAlD
Amiloride—Encephalopathy—Capecitabine—esophageal cancer	0.0027	0.0214	CcSEcCtD
Amiloride—SLC22A4—lung—esophageal cancer	0.00263	0.00686	CbGeAlD
Amiloride—Hyperuricaemia—Cisplatin—esophageal cancer	0.00253	0.0201	CcSEcCtD
Amiloride—Pain—Carboplatin—esophageal cancer	0.00245	0.0194	CcSEcCtD
Amiloride—Blood uric acid increased—Cisplatin—esophageal cancer	0.00239	0.019	CcSEcCtD
Amiloride—Hepatocellular injury—Cisplatin—esophageal cancer	0.00235	0.0187	CcSEcCtD
Amiloride—Hyperkalaemia—Cisplatin—esophageal cancer	0.00231	0.0183	CcSEcCtD
Amiloride—Encephalopathy—Methotrexate—esophageal cancer	0.00201	0.016	CcSEcCtD
Amiloride—Polyuria—Cisplatin—esophageal cancer	0.00194	0.0154	CcSEcCtD
Amiloride—Liver disorder—Methotrexate—esophageal cancer	0.00189	0.015	CcSEcCtD
Amiloride—Nasal congestion—Cisplatin—esophageal cancer	0.00187	0.0149	CcSEcCtD
Amiloride—SLC22A4—lymph node—esophageal cancer	0.0018	0.00469	CbGeAlD
Amiloride—Neck pain—Capecitabine—esophageal cancer	0.00175	0.0139	CcSEcCtD
Amiloride—Hyponatraemia—Cisplatin—esophageal cancer	0.00171	0.0136	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00171	0.0135	CcSEcCtD
Amiloride—Urine output increased—Capecitabine—esophageal cancer	0.00157	0.0124	CcSEcCtD
Amiloride—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00156	0.0124	CcSEcCtD
Amiloride—Cramp muscle—Cisplatin—esophageal cancer	0.00154	0.0122	CcSEcCtD
Amiloride—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00144	0.0114	CcSEcCtD
Amiloride—Polyuria—Capecitabine—esophageal cancer	0.00143	0.0114	CcSEcCtD
Amiloride—Hyperuricaemia—Methotrexate—esophageal cancer	0.00139	0.011	CcSEcCtD
Amiloride—Libido decreased—Capecitabine—esophageal cancer	0.00136	0.0108	CcSEcCtD
Amiloride—Thirst—Capecitabine—esophageal cancer	0.00132	0.0105	CcSEcCtD
Amiloride—Blood uric acid increased—Methotrexate—esophageal cancer	0.00131	0.0104	CcSEcCtD
Amiloride—Hyponatraemia—Capecitabine—esophageal cancer	0.00126	0.01	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00126	0.00999	CcSEcCtD
Amiloride—Pain in extremity—Capecitabine—esophageal cancer	0.00126	0.00999	CcSEcCtD
Amiloride—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00125	0.00991	CcSEcCtD
Amiloride—Aplastic anaemia—Methotrexate—esophageal cancer	0.00121	0.00962	CcSEcCtD
Amiloride—Bradycardia—Cisplatin—esophageal cancer	0.0012	0.00954	CcSEcCtD
Amiloride—Coma—Methotrexate—esophageal cancer	0.00118	0.00936	CcSEcCtD
Amiloride—Urine output increased—Methotrexate—esophageal cancer	0.00117	0.00926	CcSEcCtD
Amiloride—Gynaecomastia—Methotrexate—esophageal cancer	0.00115	0.00916	CcSEcCtD
Amiloride—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00115	0.00912	CcSEcCtD
Amiloride—Visual impairment—Cisplatin—esophageal cancer	0.00114	0.00903	CcSEcCtD
Amiloride—Muscular weakness—Capecitabine—esophageal cancer	0.00111	0.00881	CcSEcCtD
Amiloride—Tinnitus—Cisplatin—esophageal cancer	0.0011	0.00874	CcSEcCtD
Amiloride—Abdominal distension—Capecitabine—esophageal cancer	0.00109	0.00869	CcSEcCtD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00109	0.00222	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CREBBP—esophageal cancer	0.00107	0.00219	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CCND1—esophageal cancer	0.00107	0.00219	CbGpPWpGaD
Amiloride—Polyuria—Methotrexate—esophageal cancer	0.00107	0.00847	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00106	0.00217	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00106	0.00217	CbGpPWpGaD
Amiloride—Angina pectoris—Capecitabine—esophageal cancer	0.00106	0.00841	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00105	0.00213	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—RB1—esophageal cancer	0.00104	0.00213	CbGpPWpGaD
Amiloride—Alopecia—Cisplatin—esophageal cancer	0.00104	0.00828	CcSEcCtD
Amiloride—Dysuria—Capecitabine—esophageal cancer	0.00102	0.00807	CcSEcCtD
Amiloride—Neutropenia—Capecitabine—esophageal cancer	0.00102	0.00807	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00102	0.00207	CbGpPWpGaD
Amiloride—Flatulence—Cisplatin—esophageal cancer	0.00101	0.00804	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—CDKN1A—esophageal cancer	0.001	0.00204	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PFN1—esophageal cancer	0.000998	0.00203	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000997	0.00203	CbGpPWpGaD
Amiloride—Visual disturbance—Methotrexate—esophageal cancer	0.000988	0.00785	CcSEcCtD
Amiloride—Muscle spasms—Cisplatin—esophageal cancer	0.000988	0.00784	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—EP300—esophageal cancer	0.000988	0.00201	CbGpPWpGaD
Amiloride—Depression—Capecitabine—esophageal cancer	0.000967	0.00767	CcSEcCtD
Amiloride—Tremor—Cisplatin—esophageal cancer	0.000963	0.00764	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000958	0.00195	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—EP300—esophageal cancer	0.000955	0.00195	CbGpPWpGaD
Amiloride—Jaundice—Capecitabine—esophageal cancer	0.000945	0.0075	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.000929	0.00189	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—esophageal cancer	0.000918	0.00187	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—BCL2—esophageal cancer	0.000904	0.00184	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—PIK3CA—esophageal cancer	0.000899	0.00183	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000892	0.00182	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—esophageal cancer	0.000891	0.00182	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—esophageal cancer	0.000891	0.00181	CbGpPWpGaD
Amiloride—Bradycardia—Capecitabine—esophageal cancer	0.000886	0.00703	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—BCL2—esophageal cancer	0.000877	0.00179	CbGpPWpGaD
Amiloride—Haemoglobin—Capecitabine—esophageal cancer	0.000875	0.00694	CcSEcCtD
Amiloride—Haemorrhage—Capecitabine—esophageal cancer	0.00087	0.00691	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—MYC—esophageal cancer	0.000861	0.00175	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SLC52A3—esophageal cancer	0.000858	0.00175	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000856	0.00174	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ERBB2—esophageal cancer	0.000852	0.00174	CbGpPWpGaD
Amiloride—Visual impairment—Capecitabine—esophageal cancer	0.000839	0.00666	CcSEcCtD
Amiloride—PLAU—E2F transcription factor network—MYC—esophageal cancer	0.000832	0.00169	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KMT2D—esophageal cancer	0.000819	0.00167	CbGpPWpGaD
Amiloride—Tinnitus—Capecitabine—esophageal cancer	0.000811	0.00644	CcSEcCtD
Amiloride—PLAU—Hemostasis—CFL1—esophageal cancer	0.000809	0.00165	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000806	0.00164	CbGpPWpGaD
Amiloride—Anorexia—Cisplatin—esophageal cancer	0.0008	0.00635	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—CCND1—esophageal cancer	0.000794	0.00162	CbGpPWpGaD
Amiloride—Alopecia—Capecitabine—esophageal cancer	0.000769	0.00611	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000764	0.00607	CcSEcCtD
Amiloride—PLAU—Hemostasis—GNG7—esophageal cancer	0.000762	0.00155	CbGpPWpGaD
Amiloride—Neutropenia—Methotrexate—esophageal cancer	0.000757	0.00601	CcSEcCtD
Amiloride—Dysuria—Methotrexate—esophageal cancer	0.000757	0.00601	CcSEcCtD
Amiloride—Paraesthesia—Cisplatin—esophageal cancer	0.000753	0.00598	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CCND1—esophageal cancer	0.000753	0.00153	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN1A—esophageal cancer	0.00075	0.00153	CbGpPWpGaD
Amiloride—Dyspnoea—Cisplatin—esophageal cancer	0.000748	0.00594	CcSEcCtD
Amiloride—Flatulence—Capecitabine—esophageal cancer	0.000747	0.00593	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—esophageal cancer	0.000745	0.00592	CcSEcCtD
Amiloride—Back pain—Capecitabine—esophageal cancer	0.000733	0.00582	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000732	0.00149	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—EP300—esophageal cancer	0.000731	0.00149	CbGpPWpGaD
Amiloride—Decreased appetite—Cisplatin—esophageal cancer	0.000729	0.00579	CcSEcCtD
Amiloride—Muscle spasms—Capecitabine—esophageal cancer	0.000728	0.00578	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN1A—esophageal cancer	0.000728	0.00148	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000724	0.00575	CcSEcCtD
Amiloride—Depression—Methotrexate—esophageal cancer	0.00072	0.00571	CcSEcCtD
Amiloride—SLC9A1—Metabolism—BLVRB—esophageal cancer	0.000719	0.00146	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC52A3—esophageal cancer	0.000719	0.00146	CbGpPWpGaD
Amiloride—Pain—Cisplatin—esophageal cancer	0.000717	0.00569	CcSEcCtD
Amiloride—Tremor—Capecitabine—esophageal cancer	0.00071	0.00564	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—TP53—esophageal cancer	0.000707	0.00144	CbGpPWpGaD
Amiloride—Feeling abnormal—Cisplatin—esophageal cancer	0.000691	0.00549	CcSEcCtD
Amiloride—Vertigo—Capecitabine—esophageal cancer	0.000681	0.0054	CcSEcCtD
Amiloride—SCNN1G—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000676	0.00138	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000676	0.00138	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000676	0.00138	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000676	0.00138	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000676	0.00138	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—esophageal cancer	0.000675	0.00137	CbGpPWpGaD
Amiloride—Palpitations—Capecitabine—esophageal cancer	0.00067	0.00532	CcSEcCtD
Amiloride—Cough—Capecitabine—esophageal cancer	0.000661	0.00525	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—esophageal cancer	0.000651	0.00517	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000649	0.00132	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000649	0.00132	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000649	0.00132	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000649	0.00132	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000649	0.00132	CbGpPWpGaD
Amiloride—Haemorrhage—Methotrexate—esophageal cancer	0.000648	0.00514	CcSEcCtD
Amiloride—Chest pain—Capecitabine—esophageal cancer	0.000645	0.00512	CcSEcCtD
Amiloride—Arthralgia—Capecitabine—esophageal cancer	0.000645	0.00512	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—esophageal cancer	0.000637	0.0013	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FKBP1A—esophageal cancer	0.000635	0.00129	CbGpPWpGaD
Amiloride—Visual impairment—Methotrexate—esophageal cancer	0.000624	0.00496	CcSEcCtD
Amiloride—Confusional state—Capecitabine—esophageal cancer	0.000623	0.00495	CcSEcCtD
Amiloride—PLAU—Hemostasis—HSPA5—esophageal cancer	0.000621	0.00127	CbGpPWpGaD
Amiloride—SLC9A1—Disease—DOCK2—esophageal cancer	0.000621	0.00126	CbGpPWpGaD
Amiloride—SLC9A1—Disease—WIF1—esophageal cancer	0.000621	0.00126	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC10A2—esophageal cancer	0.000611	0.00124	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CA1—esophageal cancer	0.000611	0.00124	CbGpPWpGaD
Amiloride—Shock—Capecitabine—esophageal cancer	0.000608	0.00483	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—esophageal cancer	0.000604	0.0048	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—esophageal cancer	0.000604	0.00123	CbGpPWpGaD
Amiloride—Asthenia—Cisplatin—esophageal cancer	0.000602	0.00478	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000597	0.00122	CbGpPWpGaD
Amiloride—Anorexia—Capecitabine—esophageal cancer	0.000589	0.00468	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—PIK3CA—esophageal cancer	0.000586	0.00119	CbGpPWpGaD
Amiloride—Diarrhoea—Cisplatin—esophageal cancer	0.000574	0.00456	CcSEcCtD
Amiloride—SLC9A1—Disease—CSNK1A1—esophageal cancer	0.000573	0.00117	CbGpPWpGaD
Amiloride—Alopecia—Methotrexate—esophageal cancer	0.000573	0.00455	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000572	0.00117	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000563	0.00447	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000561	0.00114	CbGpPWpGaD
Amiloride—Insomnia—Capecitabine—esophageal cancer	0.000559	0.00444	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CA2—esophageal cancer	0.000559	0.00114	CbGpPWpGaD
Amiloride—Paraesthesia—Capecitabine—esophageal cancer	0.000555	0.00441	CcSEcCtD
Amiloride—Dyspnoea—Capecitabine—esophageal cancer	0.000551	0.00438	CcSEcCtD
Amiloride—Back pain—Methotrexate—esophageal cancer	0.000546	0.00433	CcSEcCtD
Amiloride—Dyspepsia—Capecitabine—esophageal cancer	0.000544	0.00432	CcSEcCtD
Amiloride—Decreased appetite—Capecitabine—esophageal cancer	0.000538	0.00427	CcSEcCtD
Amiloride—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000534	0.00424	CcSEcCtD
Amiloride—Vomiting—Cisplatin—esophageal cancer	0.000533	0.00423	CcSEcCtD
Amiloride—Fatigue—Capecitabine—esophageal cancer	0.000533	0.00423	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000532	0.00108	CbGpPWpGaD
Amiloride—Rash—Cisplatin—esophageal cancer	0.000529	0.0042	CcSEcCtD
Amiloride—Pain—Capecitabine—esophageal cancer	0.000529	0.0042	CcSEcCtD
Amiloride—Constipation—Capecitabine—esophageal cancer	0.000529	0.0042	CcSEcCtD
Amiloride—Dermatitis—Cisplatin—esophageal cancer	0.000528	0.00419	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—esophageal cancer	0.000523	0.00107	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ADH7—esophageal cancer	0.00052	0.00106	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLCE1—esophageal cancer	0.00052	0.00106	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—esophageal cancer	0.000513	0.00104	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—esophageal cancer	0.000511	0.00104	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.00051	0.00104	CbGpPWpGaD
Amiloride—Feeling abnormal—Capecitabine—esophageal cancer	0.00051	0.00405	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000508	0.00103	CbGpPWpGaD
Amiloride—Vertigo—Methotrexate—esophageal cancer	0.000507	0.00402	CcSEcCtD
Amiloride—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000506	0.00401	CcSEcCtD
Amiloride—Nausea—Cisplatin—esophageal cancer	0.000498	0.00396	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—esophageal cancer	0.000496	0.00101	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000495	0.00101	CbGpPWpGaD
Amiloride—Cough—Methotrexate—esophageal cancer	0.000492	0.00391	CcSEcCtD
Amiloride—Abdominal pain—Capecitabine—esophageal cancer	0.000489	0.00388	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000487	0.000992	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000487	0.000992	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ELMO1—esophageal cancer	0.000481	0.00098	CbGpPWpGaD
Amiloride—Chest pain—Methotrexate—esophageal cancer	0.00048	0.00381	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—esophageal cancer	0.00048	0.00381	CcSEcCtD
Amiloride—SLC9A1—Disease—GSTO1—esophageal cancer	0.00047	0.000958	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TPI1—esophageal cancer	0.00047	0.000958	CbGpPWpGaD
Amiloride—Confusional state—Methotrexate—esophageal cancer	0.000464	0.00368	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000462	0.000941	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ABL1—esophageal cancer	0.00046	0.000938	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ADH1B—esophageal cancer	0.000456	0.000928	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000453	0.000923	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ALDOB—esophageal cancer	0.000451	0.000918	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000446	0.000908	CbGpPWpGaD
Amiloride—Asthenia—Capecitabine—esophageal cancer	0.000444	0.00352	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000443	0.000901	CbGpPWpGaD
Amiloride—Anorexia—Methotrexate—esophageal cancer	0.000439	0.00348	CcSEcCtD
Amiloride—Pruritus—Capecitabine—esophageal cancer	0.000437	0.00347	CcSEcCtD
Amiloride—SLC9A1—Metabolism—TYMP—esophageal cancer	0.000436	0.000887	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIST1H2BM—esophageal cancer	0.000434	0.000884	CbGpPWpGaD
Amiloride—SLC9A1—Disease—GAPDH—esophageal cancer	0.000434	0.000884	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000883	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000883	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000883	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000883	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000434	0.000883	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000428	0.000871	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP26A1—esophageal cancer	0.000424	0.000863	CbGpPWpGaD
Amiloride—Diarrhoea—Capecitabine—esophageal cancer	0.000423	0.00336	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000422	0.00086	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000419	0.00333	CcSEcCtD
Amiloride—Insomnia—Methotrexate—esophageal cancer	0.000416	0.00331	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—esophageal cancer	0.000413	0.00328	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALOX15—esophageal cancer	0.000413	0.000841	CbGpPWpGaD
Amiloride—Dyspnoea—Methotrexate—esophageal cancer	0.00041	0.00326	CcSEcCtD
Amiloride—Somnolence—Methotrexate—esophageal cancer	0.000409	0.00325	CcSEcCtD
Amiloride—Dizziness—Capecitabine—esophageal cancer	0.000409	0.00325	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—esophageal cancer	0.000405	0.00322	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—esophageal cancer	0.0004	0.00318	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000397	0.00315	CcSEcCtD
Amiloride—Fatigue—Methotrexate—esophageal cancer	0.000397	0.00315	CcSEcCtD
Amiloride—SLC9A1—Metabolism—TPI1—esophageal cancer	0.000394	0.000802	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTO1—esophageal cancer	0.000394	0.000802	CbGpPWpGaD
Amiloride—Pain—Methotrexate—esophageal cancer	0.000394	0.00312	CcSEcCtD
Amiloride—Vomiting—Capecitabine—esophageal cancer	0.000393	0.00312	CcSEcCtD
Amiloride—Rash—Capecitabine—esophageal cancer	0.00039	0.0031	CcSEcCtD
Amiloride—Dermatitis—Capecitabine—esophageal cancer	0.00039	0.00309	CcSEcCtD
Amiloride—Headache—Capecitabine—esophageal cancer	0.000387	0.00308	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000384	0.000783	CbGpPWpGaD
Amiloride—SLC9A1—Disease—XIAP—esophageal cancer	0.000383	0.000781	CbGpPWpGaD
Amiloride—Feeling abnormal—Methotrexate—esophageal cancer	0.000379	0.00301	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALDOB—esophageal cancer	0.000378	0.000769	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000376	0.00299	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000369	0.000751	CbGpPWpGaD
Amiloride—Nausea—Capecitabine—esophageal cancer	0.000367	0.00292	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—esophageal cancer	0.000364	0.00289	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GAPDH—esophageal cancer	0.000363	0.00074	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CRABP1—esophageal cancer	0.00036	0.000734	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00036	0.000734	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000358	0.00073	CbGpPWpGaD
Amiloride—SLC9A1—Disease—B2M—esophageal cancer	0.000356	0.000726	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GNG7—esophageal cancer	0.000343	0.000698	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ENO1—esophageal cancer	0.000342	0.000696	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSME2—esophageal cancer	0.000337	0.000686	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSME1—esophageal cancer	0.000337	0.000686	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000336	0.000684	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000335	0.000682	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS2—esophageal cancer	0.000332	0.000676	CbGpPWpGaD
Amiloride—Asthenia—Methotrexate—esophageal cancer	0.00033	0.00262	CcSEcCtD
Amiloride—Pruritus—Methotrexate—esophageal cancer	0.000326	0.00259	CcSEcCtD
Amiloride—SLC9A1—Disease—CALR—esophageal cancer	0.000323	0.000658	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALDH2—esophageal cancer	0.000321	0.000654	CbGpPWpGaD
Amiloride—Diarrhoea—Methotrexate—esophageal cancer	0.000315	0.0025	CcSEcCtD
Amiloride—SLC9A1—Disease—FBXW7—esophageal cancer	0.000313	0.000637	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTT1—esophageal cancer	0.000305	0.000622	CbGpPWpGaD
Amiloride—Dizziness—Methotrexate—esophageal cancer	0.000304	0.00242	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CYP2A6—esophageal cancer	0.000302	0.000615	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CREBBP—esophageal cancer	0.000298	0.000607	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GNG7—esophageal cancer	0.000295	0.0006	CbGpPWpGaD
Amiloride—Vomiting—Methotrexate—esophageal cancer	0.000293	0.00232	CcSEcCtD
Amiloride—Rash—Methotrexate—esophageal cancer	0.00029	0.0023	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—esophageal cancer	0.00029	0.0023	CcSEcCtD
Amiloride—Headache—Methotrexate—esophageal cancer	0.000288	0.00229	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PTGS1—esophageal cancer	0.000286	0.000583	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ENO1—esophageal cancer	0.000286	0.000583	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000286	0.000582	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000282	0.000575	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSME2—esophageal cancer	0.000282	0.000574	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PSME1—esophageal cancer	0.000282	0.000574	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ALDH2—esophageal cancer	0.000276	0.000562	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GNG7—esophageal cancer	0.000274	0.000559	CbGpPWpGaD
Amiloride—Nausea—Methotrexate—esophageal cancer	0.000273	0.00217	CcSEcCtD
Amiloride—PLAU—Hemostasis—NOS3—esophageal cancer	0.000267	0.000543	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000266	0.000541	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000263	0.000536	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ALDH2—esophageal cancer	0.000257	0.000524	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TGFBR2—esophageal cancer	0.000253	0.000515	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000252	0.000513	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000248	0.000504	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP1B1—esophageal cancer	0.000243	0.000496	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00024	0.000489	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SMAD4—esophageal cancer	0.000239	0.000487	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000235	0.000478	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00023	0.000469	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00023	0.000469	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP19A1—esophageal cancer	0.000229	0.000466	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000224	0.000456	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000215	0.000437	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000215	0.000437	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—esophageal cancer	0.000209	0.000425	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000204	0.000415	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—EP300—esophageal cancer	0.000203	0.000413	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—esophageal cancer	0.0002	0.000408	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000196	0.000399	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HIF1A—esophageal cancer	0.000196	0.000399	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—esophageal cancer	0.000178	0.000363	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOTCH1—esophageal cancer	0.000176	0.000359	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000175	0.000355	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000163	0.000331	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CREBBP—esophageal cancer	0.00016	0.000326	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000158	0.000323	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC52A3—esophageal cancer	0.000156	0.000317	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BLVRB—esophageal cancer	0.000156	0.000317	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—esophageal cancer	0.00015	0.000306	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000148	0.000301	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—esophageal cancer	0.000145	0.000296	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC52A3—esophageal cancer	0.000145	0.000295	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BLVRB—esophageal cancer	0.000145	0.000295	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—esophageal cancer	0.000143	0.000292	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CREBBP—esophageal cancer	0.000134	0.000273	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—esophageal cancer	0.000134	0.000273	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC10A2—esophageal cancer	0.000132	0.000269	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA1—esophageal cancer	0.000132	0.000269	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—esophageal cancer	0.000131	0.000267	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000131	0.000267	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA1—esophageal cancer	0.000123	0.000251	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC10A2—esophageal cancer	0.000123	0.000251	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA2—esophageal cancer	0.000121	0.000246	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—esophageal cancer	0.00012	0.000244	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—esophageal cancer	0.000114	0.000233	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA2—esophageal cancer	0.000113	0.00023	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLCE1—esophageal cancer	0.000112	0.000229	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADH7—esophageal cancer	0.000112	0.000229	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—esophageal cancer	0.00011	0.000223	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EP300—esophageal cancer	0.000109	0.000222	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADH7—esophageal cancer	0.000105	0.000214	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLCE1—esophageal cancer	0.000105	0.000214	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADH1B—esophageal cancer	9.86e-05	0.000201	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.65e-05	0.000197	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—esophageal cancer	9.49e-05	0.000193	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMP—esophageal cancer	9.43e-05	0.000192	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—esophageal cancer	9.28e-05	0.000189	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.26e-05	0.000189	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADH1B—esophageal cancer	9.19e-05	0.000187	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP26A1—esophageal cancer	9.17e-05	0.000187	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—EP300—esophageal cancer	9.12e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.99e-05	0.000183	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX15—esophageal cancer	8.94e-05	0.000182	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMP—esophageal cancer	8.79e-05	0.000179	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.63e-05	0.000176	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP26A1—esophageal cancer	8.55e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTO1—esophageal cancer	8.53e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TPI1—esophageal cancer	8.53e-05	0.000174	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX15—esophageal cancer	8.33e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDOB—esophageal cancer	8.17e-05	0.000166	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—esophageal cancer	8.06e-05	0.000164	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTO1—esophageal cancer	7.95e-05	0.000162	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TPI1—esophageal cancer	7.95e-05	0.000162	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GAPDH—esophageal cancer	7.87e-05	0.00016	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CRABP1—esophageal cancer	7.8e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDOB—esophageal cancer	7.62e-05	0.000155	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNG7—esophageal cancer	7.42e-05	0.000151	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GAPDH—esophageal cancer	7.33e-05	0.000149	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CRABP1—esophageal cancer	7.27e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH2—esophageal cancer	6.95e-05	0.000142	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNG7—esophageal cancer	6.91e-05	0.000141	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—esophageal cancer	6.75e-05	0.000137	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—esophageal cancer	6.61e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2A6—esophageal cancer	6.53e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH2—esophageal cancer	6.48e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO1—esophageal cancer	6.19e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS1—esophageal cancer	6.19e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.19e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—esophageal cancer	6.16e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSME2—esophageal cancer	6.1e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PSME1—esophageal cancer	6.1e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2A6—esophageal cancer	6.09e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO1—esophageal cancer	5.77e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS1—esophageal cancer	5.77e-05	0.000118	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.77e-05	0.000117	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSME2—esophageal cancer	5.69e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PSME1—esophageal cancer	5.69e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP1B1—esophageal cancer	5.27e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP19A1—esophageal cancer	4.95e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP1B1—esophageal cancer	4.91e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP19A1—esophageal cancer	4.62e-05	9.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—esophageal cancer	4.52e-05	9.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—esophageal cancer	4.34e-05	8.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—esophageal cancer	4.21e-05	8.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—esophageal cancer	4.04e-05	8.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CREBBP—esophageal cancer	2.9e-05	5.9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CREBBP—esophageal cancer	2.7e-05	5.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—esophageal cancer	2.6e-05	5.29e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—esophageal cancer	2.42e-05	4.93e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—esophageal cancer	2.37e-05	4.83e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—esophageal cancer	2.21e-05	4.51e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EP300—esophageal cancer	1.97e-05	4.02e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EP300—esophageal cancer	1.84e-05	3.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—esophageal cancer	1.46e-05	2.97e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.36e-05	2.77e-05	CbGpPWpGaD
